HI
SRPT icon

Handelsinvest Investeringsforvaltning’s Sarepta Therapeutics SRPT Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$267K Sell
2,059
-1,069
-34% -$131K 0.13% 197
2023
Q4 		$302K Buy
+3,128
New +$300K 0.12% 262

Other funds holding SRPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's SRPT Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its Sarepta Therapeutics (SRPT) stake by 34% in Q1 2024, selling an estimated $131K and leaving 2,059 shares worth $267K. The position accounts for 0.13% of the portfolio, ranked #197.

Handelsinvest Investeringsforvaltning first reported a position in SRPT in Q4 2023 and has held it in 2 quarters since. The position peaked at $302K in Q4 2023. 415 funds tracked by Wall St. Rank hold SRPT as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 2,059 shares of Sarepta Therapeutics worth $267K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 1,069 Sarepta Therapeutics shares in Q1 2024, an estimated $131K.
  • Sarepta Therapeutics made up 0.13% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #197 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in Sarepta Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's Sarepta Therapeutics position peaked at $302K in Q4 2023.
  • 415 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.